Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Glucose Response to Laevolac in T2DM
NCT03666546Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Nov 2018
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of lactulose in constipation, sponsored by Fresenius Kabi. Started Nov 2018; status: completed.
02
Drugs
lactulose
03
Conditions
constipation
Beyond the preview
Go deeper on NCT03666546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666546.